Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 590
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00681304 | Ultrasound Based Localization of Lumpectomy Bed in Anatomical Coordinate System | ||
| NCT01459614 | Gemcitabine/Taxotere/Xeloda (GTX) With Cisplatin in Subjects With Metastatic Pancreatic Cancer | ||
| NCT01282216 | Patient-donor Vaccination in the Context of Allogeneic Bone Marrow Transplant With Post-transplant Cyclophosphamide | ||
| NCT00714701 | Screening for Early Pancreatic Neoplasia (Cancer of the Pancreas Screening or CAPS4 Study) | ||
| NCT04177810 | Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer | ||
| NCT00287989 | Erlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer | ||
| NCT00238368 | Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant | ||
| NCT00003243 | Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer | ||
| NCT00493025 | Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery | ||
| NCT03878979 | Preoperative Immune Checkpoint Inhibitor for Patients With Primary Untreated or Recurrent/Metastatic SCCHN | ||
| NCT00293280 | Lomustine in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | ||
| NCT02259621 | Neoadjuvant Nivolumab, or Nivolumab in Combination With Ipilimumab, in Resectable NSCLC | ||
| NCT03573648 | Neoadjuvant Endocrine Therapy, Palbociclib, Avelumab in Estrogen Receptor Positive Breast Cancer | ||
| NCT03875287 | Dose-Escalation Study of E7727, an Oral Cytidine Deaminase Inhibitor With Oral Decitabine in Subjects With Solid Tumors | ||
| NCT03420521 | Nivolumab With Ipilimumab in Subjects With Neuroendocrine Tumors | ||
| NCT01750398 | Bipolar Androgen-based Therapy for Prostate Cancer (BAT) | ||
| NCT00386399 | Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene | ||
| NCT03971734 | Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas | ||
| NCT00566098 | Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma | ||
| NCT02243371 | GVAX Pancreas Vaccine (With CY) and CRS-207 With or Without Nivolumab | ||
| NCT04019964 | Nivolumab in Biochemically Recurrent dMMR Prostate Cancer | ||
| NCT03216499 | HIF-2 Alpha Inhibitor PT2385 in Treating Patients With Recurrent Glioblastoma | ||
| NCT04534309 | Behavioral Weight Loss Program for Cancer Survivors in Maryland | ||
| NCT00290732 | Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer | ||
| NCT00492921 | High-Dose Cyclophosphamide for Steroid Refractory GVHD | ||
| NCT04979000 | HPV in Sinonasal Ca: Retrospective Analysis Association of Human Papilloma Virus (HPV) Serology and Behavioral Risk Factors | ||
| NCT02556931 | Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies | ||
| NCT00027625 | Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma | ||
| NCT02716948 | SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or Spine | ||
| NCT00416949 | Iodine I 131 in Treating Patients With Thyroid Cancer | ||
| NCT01595321 | Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas | ||
| NCT02657863 | Cancer DNA Detection in Blood and Urine | ||
| NCT00003962 | Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer | ||
| NCT01728779 | Stereotactic Body Radiation With Nelfinavir for Oligometastases | ||
| NCT00004073 | Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | ||
| NCT01937039 | Johns Hopkins Breast Cancer Program Longitudinal Repository | ||
| NCT03043807 | A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy | ||
| NCT01871116 | POWER-remote Weight Loss Program in Early Stage Breast Cancer | ||
| NCT02575222 | Study of Neoadjuvant Nivolumab in Patients With Non-metastatic Stage II-IV Clear Cell Renal Cell Carcinoma | ||
| NCT01439217 | Endothelial Function, Arterial Stiffness and Components | ||
| NCT01697800 | A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract | ||
| NCT01045460 | Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma | ||
| NCT01009346 | RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic SCCHN | ||
| NCT00334542 | Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer | ||
| NCT05302570 | Neoadjuvant Short-course Hypofractionated PBT for Non-metastatic RPS | ||
| NCT01349569 | Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission | ||
| NCT00401024 | Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma | ||
| NCT00242996 | Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell Lymphoma | ||
| NCT03006302 | Epacadostat, Pembrolizumab, and CRS-207, With or Without CY/GVAX Pancreas in Patients With Metastatic Pancreas Cancer | ||
| NCT04266431 | EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer Progression |
